|

VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

RECRUITINGSponsored by W.L.Gore & Associates
Actively Recruiting
SponsorW.L.Gore & Associates
Started2026-07-20
Est. completion2029-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites

Summary

This Registry will look at patients being treated with a transjugular intrahepatic portosystemic shunt (TIPS) procedure for portal hypertension. The purpose of this Registry is to collect data on the safety and performance of the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion (6-10mm) for 2 years in real world setting. Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. The subject is eligible for treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion 6-10mm for de novo TIPS creation.
2. The subject has cirrhotic portal hypertension.
3. The subject is ≥18 years of age.
4. The subject is capable of complying with protocol requirements, including follow up.
5. The subject or legal representative signed the informed consent form (ICF).

Exclusion Criteria:

1. The subject has any portal vein thrombosis, including both occlusive and non-occlusive thrombosis.
2. The subject has received a liver transplantation. Patients on the transplant list are still eligible.
3. The subject has a life expectancy of less than 6 months.
4. The subject has extrahepatic or hepatic malignancy or a history of previous malignancy, unless treated curatively ≥5 years prior to enrollment. Subjects with non-melanoma skin cancer and/or carcinoma in situ of the cervix remain eligible.
5. The subject has inadequate functional hepatic reserve with a Model for End-Stage Liver Disease (MELD) Score of \> 25 or Child Pugh Score of \> 14.
6. The subject is enrolled in another investigational study, unless agreed in advance in writing by the Sponsor.
7. The subject is pregnant at the time of informed consent signature.
8. The subject has any other condition which in the judgement of the investigator would preclude adequate Study participation.

Conditions4

AscitesLiver DiseasePortal Hypertension Related to CirrhosisVariceal Bleeding

Locations3 sites

Georgia

1 site
Emory University Hospital
Bryan Nicholas Swilley, MD404-712-7962bryan.nicholas.swilley@emory.edu

Minnesota

1 site
University of Minnesota
Reza Talaie, MDrtalaie@umn.edu

Ohio

1 site
Cleveland Clinic
Cleveland, Ohio, 44195
Sameer Gadani, MD216-444-6640GADANIS@ccf.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.